Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2026
|
| Acceso en línea: | https://doi.org/10.5281/zenodo.19359258 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866902301842604032 |
|---|---|
| author | Alaycı, Birkan Gercek, Oyku Zeynep |
| author_facet | Alaycı, Birkan Gercek, Oyku Zeynep |
| contents | <p>This is the v1.2 release of the reproducible Python code and data for:</p> <p>The Impact of GLP-1 and Dual GIP/GLP-1 Receptor Agonists on Lean Body Mass<br>(A Systematic Review and Meta-Analysis of Phase 3/3b RCTs)</p> <p>Submitted to Diabetes, Obesity and Metabolism (2026). Manuscript ID: DOM-26-1453-OP.</p> <p>v1.2 changes (from v1.1):<br>- Prediction intervals corrected from z-approximation to t-distribution (df=k-2), consistent with R metafor predict()<br>- R cross-validation scripts: corrected stale hardcoded reference values carried over from earlier iterations (Peters' t/p, Begg's tau/p, profile likelihood tau2 CI, RVE df)<br>- Fat mass R script: corrected hardcoded lean MD constants used in ratio calculation (-1.94, -3.05, -1.20)<br>- Figure 1 regenerated with t-based PI annotation [-5.66; 1.77]</p> <p>Contains:<br>- All analysis scripts (DL, HKSJ, Bayesian grid integration, RVE, three-level model)<br>- R cross-validation scripts (metafor, clubSandwich)<br>- Raw data (meta_analysis_data_v5.csv)<br>- All generated figures<br>- run_all.py</p> <p>Permanent Zenodo archive will be linked automatically.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19359258 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | v1.2 - R cross-validated (March 2026) Alaycı, Birkan Gercek, Oyku Zeynep <p>This is the v1.2 release of the reproducible Python code and data for:</p> <p>The Impact of GLP-1 and Dual GIP/GLP-1 Receptor Agonists on Lean Body Mass<br>(A Systematic Review and Meta-Analysis of Phase 3/3b RCTs)</p> <p>Submitted to Diabetes, Obesity and Metabolism (2026). Manuscript ID: DOM-26-1453-OP.</p> <p>v1.2 changes (from v1.1):<br>- Prediction intervals corrected from z-approximation to t-distribution (df=k-2), consistent with R metafor predict()<br>- R cross-validation scripts: corrected stale hardcoded reference values carried over from earlier iterations (Peters' t/p, Begg's tau/p, profile likelihood tau2 CI, RVE df)<br>- Fat mass R script: corrected hardcoded lean MD constants used in ratio calculation (-1.94, -3.05, -1.20)<br>- Figure 1 regenerated with t-based PI annotation [-5.66; 1.77]</p> <p>Contains:<br>- All analysis scripts (DL, HKSJ, Bayesian grid integration, RVE, three-level model)<br>- R cross-validation scripts (metafor, clubSandwich)<br>- Raw data (meta_analysis_data_v5.csv)<br>- All generated figures<br>- run_all.py</p> <p>Permanent Zenodo archive will be linked automatically.</p> |
| title | v1.2 - R cross-validated (March 2026) |
| url | https://doi.org/10.5281/zenodo.19359258 |